CCL26 is upregulated by nab-paclitaxel in pancreatic cancer–associated fibroblasts and promotes PDAC invasiveness through activation of the PI3K/AKT/mTOR pathway
Year: 2021
Type: article
DOI: 10.1093/abbs/gmab032
Authors: Xuemin Chen, Yong An, Yue Zhang, Dong Xu, Tongbing Chen, Yue Yang, Weibo Chen, D i Wu, Xiaoying Zhang
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3137563680
